OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting CLDN18.2 in cancers of the gastrointestinal tract: New drugs and new indications
Jinxia Chen, Zhiyuan Xu, Can Hu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 34
Jinxia Chen, Zhiyuan Xu, Can Hu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 55
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 55
Claudin 18.2 as a novel therapeutic target
Izuma Nakayama, Changsong Qi, Yang Chen, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 5, pp. 354-369
Closed Access | Times Cited: 40
Izuma Nakayama, Changsong Qi, Yang Chen, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 5, pp. 354-369
Closed Access | Times Cited: 40
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Julien Dilly, Megan T. Hoffman, Laleh Abbassi, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2135-2161
Closed Access | Times Cited: 29
Julien Dilly, Megan T. Hoffman, Laleh Abbassi, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2135-2161
Closed Access | Times Cited: 29
Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer
Yohei Kubota, Kohei Shitara
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 12
Yohei Kubota, Kohei Shitara
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 12
Nucleic acid-based drugs for patients with solid tumours
Sebastian G. Huayamares, David Loughrey, Hyejin Kim, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 407-427
Closed Access | Times Cited: 11
Sebastian G. Huayamares, David Loughrey, Hyejin Kim, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 407-427
Closed Access | Times Cited: 11
State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez del Moral, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 725-725
Open Access | Times Cited: 11
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez del Moral, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 725-725
Open Access | Times Cited: 11
Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?
Maria Cecília Mathias-Machado, Victor Hugo Fonseca de Jesus, Alexandre A. Jácome, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 679-679
Open Access | Times Cited: 9
Maria Cecília Mathias-Machado, Victor Hugo Fonseca de Jesus, Alexandre A. Jácome, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 679-679
Open Access | Times Cited: 9
Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression
Shengde Liu, Zizhen Zhang, Lei Jiang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Shengde Liu, Zizhen Zhang, Lei Jiang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion
Valentina Angerilli, Filippo Ghelardi, Floriana Nappo, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155145-155145
Open Access | Times Cited: 6
Valentina Angerilli, Filippo Ghelardi, Floriana Nappo, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155145-155145
Open Access | Times Cited: 6
Claudin 18.2 Expression in 1,404 Digestive Tract Adenocarcinomas including 1,175 Colorectal Carcinomas: Distinct Colorectal Carcinoma Subtypes are Claudin 18.2 Positive
Kelsey McHugh, Rish K. Pai, Robert C. Grant, et al.
Modern Pathology (2025) Vol. 38, Iss. 5, pp. 100712-100712
Open Access
Kelsey McHugh, Rish K. Pai, Robert C. Grant, et al.
Modern Pathology (2025) Vol. 38, Iss. 5, pp. 100712-100712
Open Access
Overcoming immunotherapeutic drug resistance in pancreatic and colon cancers
Mario Tavakoli, Hasan Raza, Dirin Ukwade, et al.
Elsevier eBooks (2025), pp. 305-324
Closed Access
Mario Tavakoli, Hasan Raza, Dirin Ukwade, et al.
Elsevier eBooks (2025), pp. 305-324
Closed Access
Management of peritoneal gastric metastasis: An update
Antoine Mariani, Evangelia Triantafyllou, Vahan Képénékian, et al.
European Journal of Surgical Oncology (2025), pp. 109731-109731
Open Access
Antoine Mariani, Evangelia Triantafyllou, Vahan Képénékian, et al.
European Journal of Surgical Oncology (2025), pp. 109731-109731
Open Access
Development and Characterization of 4A7: A High-Affinity Monoclonal Antibody Targeting Claudin18.2
Yahui Wu, Juan Tian, Yangyihua Zhou, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 189-203
Open Access
Yahui Wu, Juan Tian, Yangyihua Zhou, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 189-203
Open Access
Antibody-drug conjugates: the clinical development in gastric cancer
Yingze Zhu, Miao Zhou, Wenyue Kong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Yingze Zhu, Miao Zhou, Wenyue Kong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Evidence to Date on the Therapeutic Potential of Zolbetuximab in Advanced Gastroesophageal Adenocarcinoma
Jane E. Rogers, Jaffer A. Ajani
Current Oncology (2024) Vol. 31, Iss. 2, pp. 769-777
Open Access | Times Cited: 4
Jane E. Rogers, Jaffer A. Ajani
Current Oncology (2024) Vol. 31, Iss. 2, pp. 769-777
Open Access | Times Cited: 4
Immunotherapy of gastric cancer: Present status and future perspectives
John K. Triantafillidis, Manousos M. Konstadoulakis, Αpostolos Papalois
World Journal of Gastroenterology (2024) Vol. 30, Iss. 8, pp. 779-793
Open Access | Times Cited: 4
John K. Triantafillidis, Manousos M. Konstadoulakis, Αpostolos Papalois
World Journal of Gastroenterology (2024) Vol. 30, Iss. 8, pp. 779-793
Open Access | Times Cited: 4
The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases
Peyton C. High, Cara Guernsey-Biddle, Shraddha Subramanian, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 890-890
Open Access | Times Cited: 3
Peyton C. High, Cara Guernsey-Biddle, Shraddha Subramanian, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 890-890
Open Access | Times Cited: 3
Heteroaryl Group Containing Trisubstituted Alkenes: Synthesis and Anti‐tumor Activity
Jiatong Li, Ao Gu, Mengyao Li
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 3
Jiatong Li, Ao Gu, Mengyao Li
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 3
Emerging Roles of Small Extracellular Vesicles in Gastrointestinal Cancer Research and Therapy
Nora Schneider, Patrick Hermann, Tim Eiseler, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 567-567
Open Access | Times Cited: 2
Nora Schneider, Patrick Hermann, Tim Eiseler, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 567-567
Open Access | Times Cited: 2
Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer
Qian Xu, Caiyan Jia, Yan Ou, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Qian Xu, Caiyan Jia, Yan Ou, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy
Zhe Ma, Zhenxing Zhou, Wenwen Duan, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 2
Zhe Ma, Zhenxing Zhou, Wenwen Duan, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 2
Biomarker-oriented chemo-immunotherapy for advanced gastric cancer
Koji Kono, Shotaro Nakajima, Kosaku Mimura
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 7, pp. 865-872
Closed Access | Times Cited: 2
Koji Kono, Shotaro Nakajima, Kosaku Mimura
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 7, pp. 865-872
Closed Access | Times Cited: 2
The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer
Yongji Zeng, A. Craig Lockhart, Ramon U. Jin
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 873-886
Closed Access | Times Cited: 2
Yongji Zeng, A. Craig Lockhart, Ramon U. Jin
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 873-886
Closed Access | Times Cited: 2
The Role of CLDN18.2 in Gastric Cancer Prognosis: A Systematic Review and Meta-Analysis
Francisco Cézar Aquino de Moraes, Luis Eduardo Rodrigues Sobreira, Maria Eduarda Cavalcanti Souza, et al.
Biomarkers (2024), pp. 1-14
Closed Access | Times Cited: 2
Francisco Cézar Aquino de Moraes, Luis Eduardo Rodrigues Sobreira, Maria Eduarda Cavalcanti Souza, et al.
Biomarkers (2024), pp. 1-14
Closed Access | Times Cited: 2
Molecular Pathology of Gastroesophageal Cancer
Matthew D. Stachler, Ramon U. Jin
Clinics in Laboratory Medicine (2024) Vol. 44, Iss. 2, pp. 239-254
Closed Access | Times Cited: 1
Matthew D. Stachler, Ramon U. Jin
Clinics in Laboratory Medicine (2024) Vol. 44, Iss. 2, pp. 239-254
Closed Access | Times Cited: 1
